20 min listen
COVID-19 Update 5: Convalescent Serum Studies, With Drs. Laura Michaelis and Parameswaran Hari
FromThe Hematologist
COVID-19 Update 5: Convalescent Serum Studies, With Drs. Laura Michaelis and Parameswaran Hari
FromThe Hematologist
ratings:
Length:
16 minutes
Released:
Apr 16, 2020
Format:
Podcast episode
Description
In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Parameswaran Hari of Medical College of Wisconsin. They discuss convalescent serum studies, including study design and outcomes, and what it’s like getting these studies up and running given current time constraints. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org. While we regularly review and update the links, resources, and FAQs posted on the ASH website to reflect the best information available at a given point in time, the COVID-19 pandemic is a rapidly evolving global health crisis. Please take note of the dates of publication for each podcast.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Apr 16, 2020
Format:
Podcast episode
Titles in the series (100)
A Conversation about the TWiTCH Trial with Dr. Russell Ware and Dr. Michael DeBaun: In his Diffusion article from the March/April issue of The Hematologist, Dr. Michael DeBaun (Vanderbilt University School of Medicine) takes a look at the TWiTCH Trial, a multicenter, open-label, phase III, non-inferiority trial. Dr. Russell Ware (Univers by The Hematologist